Genetic abnormalities are one of the most common features observed in AML patients, of which genetic variations of the FLT3, NPM1, DNMT3A, IDH1/2, and WT1 genes have been given more attention [3,7]. This evidence concerns the gene FLT3 and acute myeloid leukemia.